FDA Approves New treatment option for cutting bleeding in Hemophilia A or B Dr. Kamal Kant Kohli12 Oct 2024 11:00 AM ISTHemophilia A and hemophilia B are genetic bleeding disorders caused by a dysfunction or deficiency of coagulation factor VIII (FVIII) or IX (FIX),...
Monthly fitusiran injections effective for bleeding reduction in patients with haemophilia A and B, study shows Dr. Kamal Kant Kohli6 April 2023 8:00 PM ISTUSA: Monthly prophylactic injections of fitusiran have shown promise in reducing bleeds in patients with haemophillia A or B, according to randomised...
Medical Bulletin 11/March/2023 Isra Zaman13 March 2023 11:04 AM ISTHere are the top medical news for the day:Heart inflammation after COVID vaccine examined in new studyBillions of people worldwide have received at...
Potential hemophilia treatment trial Isra Zaman11 March 2023 9:45 AM ISTHemophilia A is a rare bleeding disorder caused by a mutation in the gene encoding factor VIII, effectively stopping clotting activity. The condition...
Sanofi gets USFDA breakthrough therapy designation for hemophilia A drug Efanesoctocog alfa Ruchika Sharma2 Jun 2022 5:03 PM ISTHemophilia A occurs in about one in 5,000 male births annually, and more rarely in females.
USFDA warns against rare bleeding risk of JnJ COVID vaccine Ruchika Sharma12 Jan 2022 4:15 PM ISTNew Delhi: The U.S. Food and Drug Administration on Tuesday amended the fact sheet for Johnson & Johnson's COVID-19 vaccine to include a rare...
ASH 2021 guidelines on the management of von Willebrand disease Medha Baranwal7 Feb 2021 11:00 PM ISTUSA: A panel of experts from four esteemed organizations have released 2021 guideline on the management of von Willebrand disease. The guideline,...
Death after tonsillectomy : ENT Surgeon absolved of Medical Negligence Sanchari Chattopadhyay1 Jan 2021 3:44 PM ISTDelhi: Setting aside the Kerala state consumer commission's decision, the National Consumer Dispute Redressal Commission (NCDRC) has dismissed a case...
World Hemophilia day: 80 per cent cases undiagnosed in India Medical Dialogues Bureau17 April 2019 9:45 AM ISTCurrently, only about 20,000 patients are registered with Hemophilia Federation of India while over 1.5 lakh are still not brought under the registry...
FDA approves Baxalta's drug Adynovate for rare bleeding disorder Meghna A Singhania15 Nov 2015 3:51 PM ISTThe U.S. Food and Drug Administration today approved Adynovate, Antihemophilic Factor (Recombinant), PEGylated for use in adults and adolescents, aged...
